Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →44
🟠 Elevated
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,100
Total Claims
$594K
Drug Cost
345
Beneficiaries
$1,722
Cost/Patient
Risk Score Breakdown 44/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+447%
Opioid rate vs peers
50.2% vs 9.2% avg
+139%
Cost per patient vs peers
$1,722 vs $719 avg
+18%
Brand preference vs peers
7.9% vs 6.7% avg
Opioid Prescribing
50.2%
Opioid Rate
3,064
Opioid Claims
$309K
Opioid Cost
32.0%
Long-Acting Rate
This provider's opioid prescribing rate of 50.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 479 claims · $303K
Generic: 5,621 claims · $291K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl/Naloxone Hcl | 337 | $69K |
| Tapentadol Hcl | 46 | $43K |
| Oxycodone Myristate | 56 | $38K |
| Oxycodone Hcl | 28 | $35K |
| Oxymorphone Hcl | 52 | $31K |
| Buprenorphine Hcl | 26 | $25K |
| Rimegepant Sulfate | 16 | $23K |
| Oxycodone Hcl/Acetaminophen | 553 | $23K |
| Hydrocodone/Acetaminophen | 670 | $20K |
| Morphine Sulfate | 563 | $18K |
| Tapentadol Hcl | 14 | $17K |
| Fentanyl | 130 | $17K |
| Buprenorphine Hcl/Naloxone Hcl | 27 | $15K |
| Gabapentin Enacarbil | 12 | $12K |
| Hydromorphone Hcl | 37 | $12K |
Prescribing Profile
58
Unique Drugs
44.0
Anomaly Score
Patient Profile
66
Avg Age
68%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About